Renate Thalhammer-Scherrer

829 total citations
19 papers, 633 citations indexed

About

Renate Thalhammer-Scherrer is a scholar working on Hematology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Renate Thalhammer-Scherrer has authored 19 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Pharmacology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Renate Thalhammer-Scherrer's work include Acute Myeloid Leukemia Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Renate Thalhammer-Scherrer is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Renate Thalhammer-Scherrer collaborates with scholars based in Austria, United Kingdom and United States. Renate Thalhammer-Scherrer's co-authors include Ilse Schwarzinger, Mario Veitl, Katharina Ruzicka, Klaus Lechner, Christa Fonatsch, Heinz Burgmann, Florian Thalhammer, Ulrich Jaeger, Friederike Traunmüller and Gerlinde Mitterbauer and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Renate Thalhammer-Scherrer

17 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renate Thalhammer-Scherrer Austria 15 229 149 143 116 111 19 633
Christian Schörgenhofer Austria 14 169 0.7× 15 0.1× 105 0.7× 20 0.2× 55 0.5× 35 625
Marcello Mariani Italy 15 63 0.3× 27 0.2× 87 0.6× 33 0.3× 166 1.5× 57 713
Jill James New Zealand 6 100 0.4× 92 0.6× 48 0.3× 111 1.0× 11 0.1× 9 557
Claude E. Forkner United States 10 141 0.6× 14 0.1× 87 0.6× 97 0.8× 39 0.4× 16 763
Dietra D. Millard United States 8 144 0.6× 47 0.3× 106 0.7× 110 0.9× 81 0.7× 16 598
Nina Buchtele Austria 12 102 0.4× 15 0.1× 120 0.8× 56 0.5× 29 0.3× 64 563
Cal Matsumoto United States 21 53 0.2× 18 0.1× 237 1.7× 228 2.0× 84 0.8× 82 1.4k
Young Ae Lim South Korea 14 173 0.8× 14 0.1× 52 0.4× 111 1.0× 60 0.5× 80 578
Daanish Hoda United States 13 120 0.5× 13 0.1× 152 1.1× 44 0.4× 56 0.5× 43 725
Gershon H. Growe Canada 7 186 0.8× 52 0.3× 57 0.4× 9 0.1× 15 0.1× 13 460

Countries citing papers authored by Renate Thalhammer-Scherrer

Since Specialization
Citations

This map shows the geographic impact of Renate Thalhammer-Scherrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renate Thalhammer-Scherrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renate Thalhammer-Scherrer more than expected).

Fields of papers citing papers by Renate Thalhammer-Scherrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renate Thalhammer-Scherrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renate Thalhammer-Scherrer. The network helps show where Renate Thalhammer-Scherrer may publish in the future.

Co-authorship network of co-authors of Renate Thalhammer-Scherrer

This figure shows the co-authorship network connecting the top 25 collaborators of Renate Thalhammer-Scherrer. A scholar is included among the top collaborators of Renate Thalhammer-Scherrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renate Thalhammer-Scherrer. Renate Thalhammer-Scherrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wimazal, Friedrich, Wolfgang R. Sperr, Michael Kundi, et al.. (2008). Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes. Annals of Oncology. 19(5). 970–976. 33 indexed citations
2.
Sperr, Wolfgang R., Maria Piribauer, Friedrich Wimazal, et al.. (2004). A Novel Effective and Safe Consolidation for Patients Over 60 Years with Acute Myeloid Leukemia. Clinical Cancer Research. 10(12). 3965–3971. 18 indexed citations
3.
Meyer, B, Friederike Traunmüller, Ahmad Hamwi, et al.. (2004). Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage. International Journal of Clinical Pharmacology and Therapeutics. 42(10). 556–560. 17 indexed citations
4.
Thalhammer-Scherrer, Renate, Gerlinde Mitterbauer, Ingrid Simonitsch, et al.. (2002). The Immunophenotype of 325 Adult Acute Leukemias. American Journal of Clinical Pathology. 117(3). 380–389. 51 indexed citations
5.
6.
Wimazal, Friedrich, Wolfgang R. Sperr, Michael Kundi, et al.. (2001). Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes. Leukemia Research. 25(4). 287–294. 34 indexed citations
7.
Ruzicka, Katharina, Mario Veitl, Renate Thalhammer-Scherrer, & Ilse Schwarzinger. (2001). The New Hematology Analyzer Sysmex XE-2100. Archives of Pathology & Laboratory Medicine. 125(3). 391–396. 93 indexed citations
8.
Ruzicka, Katharina, Mario Veitl, Renate Thalhammer-Scherrer, & Ilse Schwarzinger. (2001). The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology.. Archives of Pathology & Laboratory Medicine. 125(3). 391–6. 84 indexed citations
9.
Thalhammer-Scherrer, Renate, Klaus Geißler, Ilse Schwarzinger, et al.. (2000). Fludarabine therapy in Waldenström's macroglobulinemia. Annals of Hematology. 79(10). 556–559. 26 indexed citations
10.
Gisslinger, Bettina, et al.. (2000). Macrocytic anemia and thrombocytosis associated with thymoma: A case report. American Journal of Hematology. 63(1). 38–41. 4 indexed citations
11.
Thalhammer-Scherrer, Renate, Mario Veitl, Markus Exner, et al.. (2000). Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice. Cytometry. 42(1). 5–10. 3 indexed citations
12.
Schmaldienst, Sabine, Friederike Traunmüller, Heinz Burgmann, et al.. (2000). Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes. European Journal of Clinical Pharmacology. 56(1). 61–64. 26 indexed citations
13.
Thalhammer-Scherrer, Renate, Mario Veitl, Markus Exner, et al.. (2000). Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice. Cytometry. 42(1). 5–5.
14.
Thalhammer, Florian, Friederike Traunmüller, Ibrahim El Menyawi, et al.. (1999). Continuous infusion versus intermittent administration of meropenem in critically ill patients. Journal of Antimicrobial Chemotherapy. 43(4). 523–527. 99 indexed citations
15.
Mitterbauer, Gerlinde, Christine L. Zimmer, Christa Fonatsch, et al.. (1999). Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR. Leukemia. 13(10). 1519–1524. 37 indexed citations
16.
Thalhammer-Scherrer, Renate, Georg Wieselthaler, Paul Knoebl, et al.. (1999). Post-transplant acute myeloid leukemia (PT-AML). Leukemia. 13(3). 321–326. 35 indexed citations
17.
18.
Thalhammer-Scherrer, Renate, et al.. (1997). Automated five-part white blood cell differential counts. Efficiency of software-generated white blood cell suspect flags of the hematology analyzers Sysmex SE-9000, Sysmex NE-8000, and Coulter STKS.. PubMed. 121(6). 573–7. 15 indexed citations
19.
Thalhammer, Florian, Heinz Burgmann, W. Graninger, et al.. (1997). Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.. PubMed. 109(10). 362–5. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Schörgenhofer Breakdown of academic impact, for papers by Marcello Mariani Breakdown of academic impact, for papers by Jill James Breakdown of academic impact, for papers by Claude E. Forkner Breakdown of academic impact, for papers by Dietra D. Millard Breakdown of academic impact, for papers by Nina Buchtele Breakdown of academic impact, for papers by Cal Matsumoto Breakdown of academic impact, for papers by Young Ae Lim Breakdown of academic impact, for papers by Daanish Hoda Breakdown of academic impact, for papers by Gershon H. Growe
Rankless by CCL
2026